Cargando…

Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells

The R5 subfamily of receptor-type protein tyrosine phosphatases (RPTPs) comprises PTPRZ and PTPRG. A recent study on primary human glioblastomas suggested a close association between PTPRZ1 (human PTPRZ) expression and cancer stemness. However, the functional roles of PTPRZ activity in glioma stem c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujikawa, Akihiro, Sugawara, Hajime, Tanaka, Taisaku, Matsumoto, Masahito, Kuboyama, Kazuya, Suzuki, Ryoko, Tanga, Naomi, Ogata, Atsuto, Masumura, Makoto, Noda, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514153/ https://www.ncbi.nlm.nih.gov/pubmed/28717188 http://dx.doi.org/10.1038/s41598-017-05931-8

Ejemplares similares

Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma
por: Fujikawa, Akihiro, et al.
Publicado: (2016)

Specific Dephosphorylation at Tyr-554 of Git1 by Ptprz Promotes Its Association with Paxillin and Hic-5
por: Fujikawa, Akihiro, et al.
Publicado: (2015)

Behavioral and neurological analyses of adult mice carrying null and distinct loss-of-receptor function mutations in protein tyrosine phosphatase receptor type Z (PTPRZ)
por: Tanga, Naomi, et al.
Publicado: (2019)

Protein Tyrosine Phosphatase Receptor Type Z Negatively Regulates Oligodendrocyte Differentiation and Myelination
por: Kuboyama, Kazuya, et al.
Publicado: (2012)

Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation
por: Kuboyama, Kazuya, et al.
Publicado: (2017)

Channel Properties of Na(x) Expressed in Neurons
por: Matsumoto, Masahito, et al.
Publicado: (2015)

Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty
por: Fujikawa, Akihiro, et al.
Publicado: (2019)

Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
por: Shi, Yu, et al.
Publicado: (2017)

Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma
por: Zeng, A-L, et al.
Publicado: (2017)

PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma
por: Makinoshima, Hideki, et al.
Publicado: (2012)

RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
por: Bao, Zhao-Shi, et al.
Publicado: (2014)

Role of pleiotrophin-protein tyrosine phosphatase receptor type Z signaling in myelination
por: Fujikawa, Akihiro, et al.
Publicado: (2016)

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme
por: Chen, Bao-Shi, et al.
Publicado: (2020)

Sprouty2 enhances the tumorigenic potential of glioblastoma cells
por: Park, Jong-Whi, et al.
Publicado: (2018)

Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZ-B differentially regulate glioma cell growth and motility
por: Bourgonje, Annika M., et al.
Publicado: (2014)

The Expression, Functions, Interactions and Prognostic Values of PTPRZ1: A Review and Bioinformatic Analysis
por: Xia, Zhenkun, et al.
Publicado: (2019)

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
por: Lamballe, Fabienne, et al.
Publicado: (2016)

Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
por: Zhang, Fengyu, et al.
Publicado: (2020)

Snail depletes the tumorigenic potential of glioblastoma
por: Savary, K, et al.
Publicado: (2013)

Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
por: Tenan, Mirna, et al.
Publicado: (2000)

REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
por: Conti, Luciano, et al.
Publicado: (2012)

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
por: Golebiewska, Anna, et al.
Publicado: (2013)

Correction: REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
Publicado: (2015)

Overexpression of PTPRZ1 Regulates p120/β-Catenin Phosphorylation to Promote Carcinogenesis of Oral Submucous Fibrosis
por: Ma, Liwei, et al.
Publicado: (2022)

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme
por: Becker, Yvonne, et al.
Publicado: (2019)

Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity
por: Sun, Peng, et al.
Publicado: (2014)

Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
por: Mughal, Awais A., et al.
Publicado: (2015)

Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potential
por: Smith, Stuart James, et al.
Publicado: (2020)

A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR
por: Al-Mayhani, Talal F, et al.
Publicado: (2019)

GlcNAc6ST3 is a keratan sulfate sulfotransferase for the protein-tyrosine phosphatase PTPRZ in the adult brain
por: Narentuya, et al.
Publicado: (2019)

Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for glioma
por: Yamanoi, Yu, et al.
Publicado: (2020)

Recurrent PTPRZ1‐MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases
por: Chai, Rui‐Chao, et al.
Publicado: (2021)

Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche
por: Caylioglu, Deniz, et al.
Publicado: (2021)

Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms
por: Rodini, Carolina Oliveira, et al.
Publicado: (2018)

Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
por: Donoghue, Jacqueline F., et al.
Publicado: (2018)

Elucidating the Anti-Tumorigenic Efficacy of Oltipraz, a Dithiolethione, in Glioblastoma
por: Kapoor-Narula, Upasana, et al.
Publicado: (2022)

RNAi-mediated knockdown of E2F2 inhibits tumorigenicity of human glioblastoma cells
por: NAKAHATA, ADRIANA M., et al.
Publicado: (2014)

Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
por: Manou, Dimitra, et al.
Publicado: (2020)

High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation
por: Huang, Ruoyu, et al.
Publicado: (2021)

Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells
por: Huang, Peng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eefu0i81n7jo3h3snamajd9vs5